Trinity Biotech plc

Trinity Biotech plc

NNASDAQ:TRIB
5.38
USD
-0.72
(-11.89%)
Dec 10Next Earn

Important Dates

Trinity Biotech plc's next confirmed earnings release is scheduled for December 10, 2026.

Earnings Date12/10/2026

Share Statistics

As of June 30, 2025, Trinity Biotech plc has 372.64M shares outstanding.

Shares Outstanding372.64M

Financial Position

As of June 30, 2025, Trinity Biotech plc maintains a current ratio of 1.05, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

Current Ratio1.05
Quick Ratio0.41
Debt / Equity-227.22

Financial Efficiency

These figures cover the twelve months ended June 30, 2025.

Employee Count390.50

Taxes

USD

Over the twelve months ended June 30, 2025, Trinity Biotech plc recorded 419,000.00 in income tax expense.

Income Tax419,000.00

Stock Price Statistics

USD

As of the close on November 16, 2026, Trinity Biotech plc's stock has declined approximately 79.61% over the past 52 weeks. The 50-day moving average sits at 6.85, while the 200-day moving average is 14.40.

52-Week Price Change-79.61%
50-Day Moving Average6.85
200-Day Moving Average14.40

Balance Sheet

USD

As of June 30, 2025, Trinity Biotech plc holds 1.55M in cash and equivalents against 112.56M in total debt, resulting in a net debt position of 98.16M. Total book value stands at -49.54M, with working capital of 1.48M providing operational flexibility.

Cash & Cash Equivalents1.55M
Total Debt112.56M
Net Debt98.16M
Equity (Book Value)-49.54M
Book Value Per Share-0.13
Working Capital1.48M

Cash Flow

USD

These figures cover the twelve months ended June 30, 2025.

Capital Expenditures-8.60M

Stock Splits

Trinity Biotech plc's most recent stock split took place on July 24, 2026 with a 30:1 split ratio.

Last Split Date7/24/2026
Split Ratio30:1